-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Galectin Therapeutics Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$1.08M, a 873% decline year-over-year.
- Galectin Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$4.62M, a 161% decline year-over-year.
- Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was -$2.99M, a 606% decline from 2022.
- Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was -$424K, a 21.8% decline from 2021.
- Galectin Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was -$348K, a 1557% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)